单次局部甲氨蝶呤注射治疗剖宫产瘢痕妊娠的安全性与有效性
回顾性队列研究纳入45例剖宫产瘢痕妊娠患者,行经阴道超声引导下单次局部甲氨蝶呤注射,单次成功率为93.3%,包括追加甲氨蝶呤后成功率达100%,无患者需子宫动脉栓塞或子宫切除术;有胎心搏动或初始hCG>100000 mIU/mL者hCG正常化时间未显著延长,23例有再生育意愿者中13例分娩14名健康新生儿。
要点
- 单次局部甲氨蝶呤注射治疗剖宫产瘢痕妊娠单次成功率为93.3%,追加甲氨蝶呤后达100%。
- 有胎心搏动或初始hCG>100000 mIU/mL者hCG正常化时间未显著延长。
- 23例有再生育意愿者中13例分娩14名健康新生儿,3例再次发生剖宫产瘢痕妊娠。
核心结论
- 单次局部甲氨蝶呤注射治疗剖宫产瘢痕妊娠安全有效,无论是否存在胎心搏动或初始hCG水平如何,并可能使后续妊娠顺利。
研究设计与样本
- 回顾性队列研究,在大学医院开展,纳入45例剖宫产瘢痕妊娠女性,干预为经阴道超声引导下单次局部甲氨蝶呤注射。
主要发现
- 平均(标准差,范围)估计孕龄为7.7(1.7,5.4-12.5)周,平均血清hCG水平为51 801(40 761,2307-187 898)mIU/mL。
- 3例需追加甲氨蝶呤治疗,无病例需子宫动脉栓塞或子宫切除术。
- 单次给药成功率为93.3%,包括追加甲氨蝶呤治疗后的成功率为100%。
- 有胎心搏动者与对照组hCG正常化平均时间分别为93.4天与77.1天(p=.12),初始hCG大于100 000 mIU/mL者与对照组分别为113.7天与83.6天(p=.10),均无显著差异。
- 23例有再生育意愿的女性中,13例分娩14名健康新生儿,3例持续妊娠,3例再次发生剖宫产瘢痕妊娠。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To investigate the safety and efficacy of a single local methotrexate (MTX) injection for the treatment of cesarean scar pregnancy (CSP), assess reproductive outcomes after treatment, and confirm clinical outcomes after the treatment of CSP patients according to the presence of fetal cardiac activity or serum human chorionic gonadotropin (hCG) levels. DESIGN: A retrospective cohort study. SETTING: A university hospital. PATIENTS: Women with CSP. INTERVENTIONS: Single local MTX injection under transvaginal ultrasound guidance. MEASUREMENTS AND MAIN RESULTS: A total of 45 CSP cases were identified; the mean (standard deviation, range) estimated gestational age was 7.7 (1.7, 5.4-12.5) weeks and the mean serum hCG level was 51 801 (40 761, 2307-187 898) mIU/mL. Three cases required additional treatment with MTX, and none of the cases needed uterine artery embolization or hysterectomy. The success rate for a single dose was 93.3%, and it was 100% if additional treatments with MTX were included. The mean time required for hCG normalization in those with fetal cardiac activity or with an initial level of hCG greater than 100 000 mIU/mL was not significantly longer than that in the controls (93.4 vs 77.1 days, p = .12; 113.7 days vs 83.6 days, p = .10). Of the 23 women who desired a subsequent pregnancy, 13 delivered 14 healthy newborns after treatment, 3 had an ongoing pregnancy, and 3 experienced recurrent CSP. CONCLUSIONS: A single local MTX injection is safe and effective for the treatment of CSP despite the presence of fetal cardiac activity or any initial level of hCG and may allow the possibility of a subsequent uneventful pregnancy.
引用
- Yamaguchi M, Ohba T, Katabuchi H, et al. Safety and Efficacy of a Single Local Methotrexate Injection for Cesarean Scar Pregnancy. J Minim Invasive Gynecol. 2021. PMID: 34808380. doi:10.1016/j.jmig.2021.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。